Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies

G Agarwal, A Hajra, S Chakraborty… - Therapeutic …, 2022 - journals.sagepub.com
Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …

[HTML][HTML] Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and …

A Babajani, K Moeinabadi-Bidgoli, F Niknejad… - Stem Cell Research & …, 2022 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.

C COVIDSurg, C GlobalSurg - Anaesthesia, 2022 - boris.unibe.ch
SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in
critically ill patients. Since surgical patients are already at higher risk of venous …

SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study

COVIDSurg Collaborative… - …, 2022 - Wiley Online Library
SARS‐CoV‐2 has been associated with an increased rate of venous thromboembolism in
critically ill patients. Since surgical patients are already at higher risk of venous …

[HTML][HTML] Incidence of deep vein thrombosis through an ultrasound surveillance protocol in patients with COVID-19 pneumonia in non-ICU setting: a multicenter …

F Pieralli, F Pomero, M Giampieri, R Marcucci… - PLoS …, 2021 - journals.plos.org
Objective The aim of this study was to assess the incidence of deep vein thrombosis (DVT)
of the lower limbs, using serial compression ultrasound (CUS) surveillance, in acutely ill …

[HTML][HTML] Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID‐19: The Swiss COVID‐HEP randomized clinical trial

M Blondon, S Cereghetti, J Pugin, C Marti… - Research and Practice …, 2022 - Elsevier
Background Hospitalized patients with COVID‐19 suffered initially from high rates of venous
thromboembolism (VTE), with possible associations between therapeutic anticoagulation …

[HTML][HTML] Risk factors and mortality of pulmonary embolism in COVID-19 patients: Evidence based on fifty observational studies

Z Fu, G Bai, B Song, Y Wang, H Song, M Ma, J Zhu… - Medicine, 2022 - journals.lww.com
Background: At present, many studies have described acute pulmonary embolism (PE) as a
frequent and prognostically relevant complication of coronavirus disease 2019 (COVID-19) …

Anticoagulation in COVID-19: A review of current literature and guidelines

B Narasimhan, M Lorente-Ros… - Hospital …, 2021 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 infections are associated with greater risk
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …

[HTML][HTML] Fibrinolytic proteins and factor XIII as predictors of thrombotic and hemorrhagic complications in hospitalized COVID-19 patients

M Marchetti, P Gomez-Rosas, L Russo… - Frontiers in …, 2022 - frontiersin.org
Introduction In a prospective cohort of hospitalized COVID-19 patients, an extensive
characterization of hemostatic alterations by both global and specific assays was performed …

[HTML][HTML] Multi-organ point-of-care ultrasound for detection of pulmonary embolism in critically ill COVID-19 patients–a diagnostic accuracy study

A Lieveld, MLA Heldeweg, JM Smit, ME Haaksma… - Journal of critical …, 2022 - Elsevier
Purpose Critically ill COVID-19 patients have an increased risk of developing pulmonary
embolism (PE). Diagnosis of PE by point-of-care ultrasound (POCUS) might reduce the …